SAFE PRESCRIBING PRACTICES IN PREGNANCY AND LACTATION

Authors

  • Wendy F. Hansen MD,

    Search for more papers by this author
    • Wendy Hansen is a Clinical Assistant Professor at the University of Iowa Hospitals and Clinics. Dr. Hansen completed a fellowship in Maternal-Fetal Medicine at The University of North Carolina School of Medicine, Chapel Hill, North Carolina in 1992.

  • Anne E. Peacock CNM, MS,

    Search for more papers by this author
    • Anne E. Peacock is Senior Nurse-Midwife at the University of Iowa since 1993. Ms. Peacock received her CNM from University of Mississippi Medical Center 1973 and an MS in Nursing University of San Diego in 1987.

  • Jerome Yankowitz MD

    Corresponding authorSearch for more papers by this author
    • Jerome Yankowitz is Associate Professor and Director, Division of Maternal-Fetal Medicine and Fetal Diagnosis and Treatment Unit at the University of Iowa Hospitals and Clinics. Dr. Yankowitz is the author Drug Therapy in Pregnancy and has served as Director, Division of Maternal-Fetal Medicine as well as Director, Maternal-Fetal Medicine Fellowship Program since 1998.


Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Iowa College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242-1080.

ABSTRACT

Midwives and other health care providers face a dilemma when a pregnant woman develops a condition that usually is treated with a pharmacologic agent. Understanding of basic teratology associated with drugs as well as the FDA categorization of agents can assist professionals in recognizing which pharmaceuticals should be used or avoided. In addition to reviewing teratology, this article addresses the use of common drugs for the treatment of upper respiratory conditions, minor pain, gastrointestinal problems, psychiatric illnesses, and neurologic disorders. In each category, current evidence is presented pertaining to which agents should be recommended for pregnant women.

Ancillary